{"organizations": [], "uuid": "cc713ae5ac7a69d671a9104ebcfbbea5b300fd6f", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 2, "shares": 2, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "uk.reuters.com", "main_image": "https://s1.reutersmedia.net/resources/r/?m=02&d=20180427&t=2&i=1255899528&w=1200&r=LYNXMPEE3Q0F0", "site_section": "http://feeds.reuters.com/reuters/UKBusinessNews/", "section_title": "Reuters: Business News", "url": "https://uk.reuters.com/article/uk-sanofi-results/sanofi-first-quarter-hit-by-exchange-rates-diabetes-growth-not-seen-before-second-half-idUKKBN1HY0HT", "country": "US", "domain_rank": 408, "title": "Sanofi first-quarter hit by exchange rates, diabetes, growth not seen before second half", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-27T08:41:00.000+03:00", "replies_count": 0, "uuid": "cc713ae5ac7a69d671a9104ebcfbbea5b300fd6f"}, "author": "", "url": "https://uk.reuters.com/article/uk-sanofi-results/sanofi-first-quarter-hit-by-exchange-rates-diabetes-growth-not-seen-before-second-half-idUKKBN1HY0HT", "ord_in_thread": 0, "title": "Sanofi first-quarter hit by exchange rates, diabetes, growth not seen before second half", "locations": [], "entities": {"persons": [{"name": "matthias blamont", "sentiment": "none"}, {"name": "ed", "sentiment": "none"}], "locations": [{"name": "paris", "sentiment": "none"}], "organizations": [{"name": "sanofi", "sentiment": "negative"}, {"name": "reuters staff", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 27, 2018 / 5:42 AM / Updated 19 minutes ago Sanofi first-quarter hit by exchange rates, diabetes, growth not seen before second half Reuters Staff 1 Min Read\nPARIS (Reuters) - French drugmaker Sanofi ( SASY.PA ) posted sluggish first-quarter profits on Friday, hurt by exchange rate effects and lower sales at its struggling diabetes and cardiovascular unit, and hinted at another difficult quarter ahead. A logo is seen in front of the entrance at the headquarters French drugmaker Sanofi in Paris October 30, 2014. REUTERS/Christian Hartmann/File Photo\nThe company, which confirmed its full year outlook, said “a “new period of growth” was expected to begin in the second half of the year.\nFirst-quarter business net income was up 0.4 percent at constant exchange rates to 1.6 billion euros (1.39 billion pounds). Total sales fell 0.4 percent to 7.9 billion.\nExchange rate movements had a negative effect of 8.3 percent.\nAnalysts polled by Reuters in partnership with Inquiry Financial had on average been expecting business net profit of 1.42 billion euros and net sales of 8 billion. Reporting by Matthias Blamont; Editing by Richard Lough", "external_links": [], "published": "2018-04-27T08:41:00.000+03:00", "crawled": "2018-04-27T09:02:08.002+03:00", "highlightTitle": ""}